Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
This intro clarifies what 2024 Total Market Return implies for portfolios, taxes, and long-term planning in plain language.
28,280 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
A new wave of personal AI assistants promises to act before you ask, with Town leading a $55 million round to connect...
Speculative growth stocks Archer Aviation and Quantum Computing slid after earnings, as burn rates and macro headwind...
As SpaceX moves deeper into the public market, investors face a volatile ride. This article lays out credible scenari...
Antalpha's bold bet on tokenized gold XAUt has yielded more than $100 million in unrealized gains, with a recent tran...
Meta’s aggressive AI infrastructure push is drawing scrutiny, but a SpaceX-like monetization model could flip the scr...
A hypothetical $1,000 XRP bet on election night would have endured wild swings and sharp turns. Here’s the latest rea...
Metaplanet announces a major move to transform its Bitcoin treasury into regulated income through a securities distri...
Hims & Hers beat quarterly EPS but trimmed full-year guidance, extending a slide in its stock as regulatory headwinds...
Lenders are elevating policy input to combat regulatory volatility, integrating advocacy into strategy. This movement...
Nike’s quarterly results hide a fragile rebound, with internal missteps and regional weakness clouding CEO Elliott Hi...
CrowdStrike accelerates an acquisition push as Palo Alto Networks doubles down on platform strategy. Both leaders rep...